ACLX
Arcellx, Inc.
NASDAQ · Healthcare · Biotechnology · US
$115.07
+0.02%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 16.73x
- Price / sales
- 302.09x
- Price / cash flow
- -32.02x
Enterprise value
- Enterprise value
- $6.4B
- EV / sales
- 286.20x
- EV / EBITDA
- -32.22x
- EV / EBIT
- -25.20x
- Market cap
- $6.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025